Skip to content
★ Sign in to follow
TE

Terence E. Winters

CEO
Immunic, Inc.
Total declarations
8
Company
1
▲ Purchases (3 ops.)
€44k
▼ Sales (0 ops.)
—

Latest filing published 15 Jun 2017 for Immunic, INC., €28k.

Filing timeline

BuySale
Terence E. Winters

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+48.1%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 15 Jun 2017 · 3434 days ago · €28k
    +103.4%
    Entry US$1,160.00 · Close at T+365 US$2,360.00
  • Filed 14 Oct 2014 · 4409 days ago · €7,937
    -56.5%
    Entry US$6,240.00 · Close at T+365 US$2,716.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Terence E. Winters: trading record in brief

Terence E. Winters discloses dealings in Immunic, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 23 April 2014 to 14 June 2017.

No open-market sale appears; the market trades are 3 purchases worth €44k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise. 2017 to date brings 1 purchase and no sales.

The median purchase comes to €7,985. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +48.1%. These figures describe past trades and do not predict future prices.

The latest filing, published on 15 June 2017, reports an open-market purchase of €28k in Immunic, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Terence E. Winters

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    Co-Chairman and CEOExecutivesImmunic, Inc.
    31,000 USD48SEC
    10,000 shares@ US$3.10100.0% of flowCommon StockSEC:0001280776-17-000074:0
    Canonical exit: 12 Sept 2017 (T+90)
  • ●
    Co-Chairman and CEOExecutivesImmunic, Inc.
    0SEC
    2,000 shares0Common StockSEC:0001628280-16-016995:0
  • ◇
    Co-Chairman and CEOExecutivesImmunic, Inc.
    55,004 USD0SEC
    128,394 shares@ US$0.4284Common StockSEC:0000899243-15-004888:0
  • ●
    Co-Chairman and CEOExecutivesImmunic, Inc.
    0SEC
    189 shares0Common StockSEC:0001209191-14-072726:0
  • ●
    Co-Chairman and CEOExecutivesImmunic, Inc.
    0SEC
    745 shares0Common StockSEC:0001209191-14-072726:1
  • ▲
    Co-Chairman and CEOExecutivesImmunic, Inc.
    10,071 USD0SEC
    680 shares@ US$14.81Common StockSEC:0001209191-14-063153:0
    Canonical exit: 8 Jan 2015 (T+90)
  • ▲
    Co-Chairman and CEOExecutivesImmunic, Inc.
    10,132 USD0SEC
    680 shares@ US$14.90Common StockSEC:0001209191-14-063153:1
    Canonical exit: 8 Jan 2015 (T+90)
  • ●
    Co-Chairman and CEOExecutivesImmunic, Inc.
    0SEC
    122,964 sharesCommon StockSEC:0001209191-14-028924:0

8 of 8 declarations